[1]
“Detection and Assessment of Drug-Related Problems Associated with Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study”, Int. J. Pharm. Sci. Lett., vol. 16, no. 1, pp. 01–04, Feb. 2026, Accessed: Mar. 22, 2026. [Online]. Available: https://ijpsl.org/index.php/ijpls/article/view/85